Symposium 10 Novel Therapeutic Targets on the Surface of Myeloma Cells in Association with Marrow Microenvironment

[SY10-4] Targeting B-cell maturation antigen with T-cell bispecific antibodies for the treatment of malignant plasma cell dyscrasias: preclinical and clinical development of EM801

Dirk Hose, Anja Seckinger (Universitaetsklinikum Heidelberg, Labor fuer Myelomforschung, Germany)

MILITARY SERVICE
10.1988-12.1989 3. FArt. Btl. 21, Schwalmstadt
HIGHER EDUCATION
10.1989-09.1996 Study of physics
04.1993-03.2002 Study of medicine
05.2007-11.2009 Doctoral thesis (Dr. med., Ruprecht-Karls-Universitaet Heidelberg)
08.2014-08.2015 Doctoral thesis (Dr. biol. hom, Justus-Liebig Universitaet Giessen)
07.2014 Habilitation (Priv.-Doz., Ruprecht-Karls-Universitaet Heidelberg)
PROFESSIONAL WORK AS PHYSICIAN AND SCIENTIST
05.2002- Dept. of Hematology, Oncology, and Rheumatology, UK Heidelberg
01.2006- Head of Multiple Myeloma Research Laboratory
AWARDS
05.2011 Young Investigator Award, XIIIth International Myeloma Workshop, Paris
09.2013 Ludwig Strauss Habilitation Award for research excellence (SFB/TRR79)
06.2018 Honorary Professorship (Prof. h.c.) University of Nanjing, China
MEMBERSHIPS
2007- Board of the German Speaking Myeloma Multicenter Group
2009- American Society of Hematology (ASH)
2015- International Myeloma Society (IMS)
2017- Deutsche Gesellschaft fr Hmatologie und Onkologie (DGHO)
2018- International Myeloma Working Group (IMWG)